Related Experiment Video
Updated: Feb 7, 2026

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
Published on: June 22, 2017
Analysis of Candidate Idarubicin Drug Resistance Genes in MOLT-3 Cells Using Exome Nuclear DNA
Tomoyoshi Komiyama1, Atsushi Ogura2, Takehito Kajiwara3
1Department of Clinical Pharmacology, Tokai University School of Medicine, Kanagawa 259-1193, Japan. komiyama@tokai-u.jp.
Abstract:
Various gene alterations related to acute leukemia are reported to be involved in drug resistance. We investigated idarubicin (IDR) resistance using exome nuclear DNA analyses of the human acute leukemia cell line MOLT-3 and the derived IDR-resistant cell line MOLT-3/IDR. We detected mutations in MOLT-3/IDR and MOLT-3 using both Genome Analysis Toolkit (GATK) and SnpEff program. We found 8839 genes with specific mutations in MOLT-3/IDR and 1162 genes with accompanying amino acid mutations. The 1162 genes were identified by exome analysis of polymerase-related genes using Kyoto Encyclopedia of Genes and Genomes (KEGG) and, among these, we identified genes with amino acid changes. In resistant strains, LIG and helicase plurality genes showed amino-acid-related changes. An amino acid mutation was also confirmed in polymerase-associated genes. Gene ontology (GO) enrichment testing was performed, and lipid-related genes were selected from the results. Fluorescent activated cell sorting (FACS) was used to determine whether IDR permeability was significantly different in MOLT-3/IDR and MOLT-3. The results showed that an IDR concentration of 0.5 μg/mL resulted in slow permeability in MOLT-3/IDR. This slow IDR permeability may be due to the effects of amino acid changes in polymerase- and lipid-associated genes.
Insights
Investigating acute leukemia drug resistance, this study found that amino acid changes in polymerase- and lipid-associated genes contribute to idarubicin resistance in MOLT-3 cells. These genetic alterations impact drug permeability.
Area of Science:
- Genetics
- Molecular Biology
- Pharmacology
Background:
- Acute leukemia is often associated with drug resistance due to various gene alterations.
- Understanding the mechanisms of drug resistance is crucial for improving treatment outcomes.
Purpose of the Study:
- To investigate the genetic basis of idarubicin (IDR) resistance in the human acute leukemia cell line MOLT-3.
- To identify specific gene mutations and their functional impact on IDR resistance.
Main Methods:
- Exome nuclear DNA analyses of MOLT-3 and IDR-resistant MOLT-3/IDR cell lines.
- Mutation detection using Genome Analysis Toolkit (GATK) and SnpEff.
- Gene identification via Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment.
- Assessment of IDR permeability using Fluorescent Activated Cell Sorting (FACS).
Main Results:
- Identified 8839 genes with mutations and 1162 genes with amino acid mutations in MOLT-3/IDR cells.
- Detected amino acid changes in polymerase- and lipid-associated genes, including LIG and helicase plurality genes.
- Observed significantly slower idarubicin permeability in MOLT-3/IDR cells at 0.5 μg/mL.
Conclusions:
- Amino acid mutations in polymerase- and lipid-associated genes are linked to idarubicin resistance in acute leukemia.
- Altered gene expression affecting drug permeability is a key mechanism of resistance.
- Findings provide insights into novel therapeutic targets for overcoming drug resistance in acute leukemia.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
Related Concept Videos
Non-nuclear Inheritance
Cell Specific Gene Expression
Nuclear Export of mRNA
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA...
Nuclear Stability
To hold positively charged protons together...
Nuclear Fusion
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...